Drawing for HIDAVEL

USPTO serial 77398468

HIDAVEL

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
HESIK, APRIL ANNE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HIDAVEL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Camille M. Miller

Camille M. Miller Cozen O'Connor1900 Market StreetPhiladelphia, PA 19103UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals for the treatment of cancer, diabetes, inflammation, cardiovascular disease and neurodegenerative diseaseACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 2, 2009MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 2, 2009ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 9, 2009CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 9, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 5, 2009EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Jan 26, 2009EX1GSOU EXTENSION 1 GRANTED—
Jan 26, 2009EXT1SOU EXTENSION 1 FILED—
Jan 26, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 30, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 8, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 18, 2008NPUBNOTICE OF PUBLICATION—
May 30, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
May 29, 2008ALIEASSIGNED TO LIE—
May 29, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 28, 2008DOCKASSIGNED TO EXAMINER—
May 14, 2008ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 7, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 7, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 21, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance